Article R5121-206 of the French Public Health Code
November 2, 2023
The detailed rules for the application of sections 1 to 12 of this chapter are determined as necessary, after obtaining the opinion of the Director General of the Agence nationale de sécurité du médicament et des produits de santé, by order of the Minister for Health. This specifies, where appropriate, the information to be included on the packaging of proprietary medicinal products intended for health establishments and the distinctive signs…
